Diffuse Large B Cell Lymphoma New Protocol: Brentuximab-Rituximab-Lenalidomide for Large Cell Lymphoma Ulas D. Bayraktar, MD 2025-04-07
Diffuse Large B Cell Lymphoma New Drug: Glofitamab for Large B Cell Lymphoma Ulas D. Bayraktar, MD 2023-09-23
Diffuse Large B Cell Lymphoma New Drug: Glofitamab in Large B-Cell Lymphoma Ulas D. Bayraktar, MD 2023-08-20
Diffuse Large B Cell Lymphoma New Protocol: Rituximab, Lenalidomide, and Ibrutinib in DLBCL Ulas D. Bayraktar, MD 2023-06-14
Diffuse Large B Cell Lymphoma Non-Hodgkin Lymphoma New Drug: Glofitamab-gxbm for selected relapsed or refractory large B-cell lymphomas Ulas D. Bayraktar, MD 2023-06-07
Diffuse Large B Cell Lymphoma New Indication: Polatuzumab in Untreated DLBCL Ulas D. Bayraktar, MD 2022-11-26
